These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 29061522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.
    Kandolin R, Lehtonen J, Kupari M.
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):303-9. PubMed ID: 21427276
    [Abstract] [Full Text] [Related]

  • 3. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
    Nery PB, Beanlands RS, Nair GM, Green M, Yang J, McArdle BA, Davis D, Ohira H, Gollob MH, Leung E, Healey JS, Birnie DH.
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
    [Abstract] [Full Text] [Related]

  • 4. FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
    Lucinian YA, Martineau P, Poenaru R, Tremblay-Gravel M, Cadrin-Tourigny J, Harel F, Pelletier-Galarneau M.
    J Nucl Cardiol; 2023 Dec; 30(6):2490-2500. PubMed ID: 37258950
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A, Wicks E, Ashworth M, Stephenson E, Guttmann O, Savvatis K, Sekhri N, Mohiddin SA, Syrris P, Menezes L, Elliott P.
    Int J Cardiol; 2019 Jun 01; 284():99-104. PubMed ID: 30409737
    [Abstract] [Full Text] [Related]

  • 6. Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
    Tung R, Bauer B, Schelbert H, Lynch JP, Auerbach M, Gupta P, Schiepers C, Chan S, Ferris J, Barrio M, Ajijola O, Bradfield J, Shivkumar K.
    Heart Rhythm; 2015 Dec 01; 12(12):2488-98. PubMed ID: 26272522
    [Abstract] [Full Text] [Related]

  • 7. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA, Birnie DH, Klein R, de Kemp RA, Leung E, Renaud J, DaSilva J, Wells GA, Beanlands RS, Nery PB.
    Circ Cardiovasc Imaging; 2013 Sep 01; 6(5):617-26. PubMed ID: 23884290
    [Abstract] [Full Text] [Related]

  • 8. Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia.
    Muser D, Santangeli P, Castro SA, Liang JJ, Enriquez A, Werner TJ, Nucifora G, Magnani S, Hayashi T, Zado ES, Garcia FC, Callans DJ, Dixit S, Desjardins B, Marchlinski FE, Alavi A.
    Eur J Nucl Med Mol Imaging; 2018 Jul 01; 45(8):1394-1404. PubMed ID: 29610956
    [Abstract] [Full Text] [Related]

  • 9. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
    Tanabe S, Nakano Y, Ando H, Fujimoto M, Onishi T, Ohashi H, Kuno S, Naito K, Waseda K, Takahashi H, Suzuki Y, Fukuta M, Amano T.
    Sci Rep; 2024 Apr 03; 14(1):7825. PubMed ID: 38570621
    [Abstract] [Full Text] [Related]

  • 10. Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis.
    Takaya Y, Kusano KF, Nakamura K, Ito H.
    Am J Cardiol; 2015 Feb 15; 115(4):505-9. PubMed ID: 25529542
    [Abstract] [Full Text] [Related]

  • 11. A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
    Cao J, Schwartz YY, Lomasney JW, Narang A, Okwuosa IS, Avery R, Passman RS, Cooper LT, Vorovich E.
    Circ Heart Fail; 2021 Mar 15; 14(3):e007800. PubMed ID: 33677978
    [No Abstract] [Full Text] [Related]

  • 12. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
    Sperry BW, Ibrahim A, Negishi K, Negishi T, Patel P, Popović ZB, Culver D, Brunken R, Marwick TH, Tamarappoo B.
    Am J Cardiol; 2017 May 15; 119(10):1663-1669. PubMed ID: 28343598
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous Reduction in Abnormal Myocardial Uptake of Fluorine-18 Fluorodeoxygluose in a Patient with Cardiac Sarcoidosis.
    Terasaki F, Fujita SI, Kanzaki Y, Hirose Y, Ishizaka N.
    Int Heart J; 2018 May 30; 59(3):647-651. PubMed ID: 29681578
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of Cardiac Sarcoidosis in Middle-Aged Adults Diagnosed with High-Grade Atrioventricular Block.
    Maizels L, Mansour M, Abu-Much A, Massalha E, Kalstein M, Beinart R, Sabbag A, Brodov Y, Goitein O, Chernomordik F, Berger M, Herscovici R, Kuperstein R, Arad M, Matetzky S, Beigel R.
    Am J Med; 2024 Apr 30; 137(4):358-365. PubMed ID: 38113953
    [Abstract] [Full Text] [Related]

  • 15. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.
    J Am Coll Cardiol; 2014 Feb 04; 63(4):329-36. PubMed ID: 24140661
    [Abstract] [Full Text] [Related]

  • 16. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H, Birnie DH, Pena E, Bernick J, Mc Ardle B, Leung E, Wells GA, Yoshinaga K, Tsujino I, Sato T, Manabe O, Oyama-Manabe N, Nishimura M, Tamaki N, Dick A, Dennie C, Klein R, Renaud J, deKemp RA, Ruddy TD, Chow BJW, Davies R, Hessian R, Liu P, Beanlands RSB, Nery PB.
    Eur J Nucl Med Mol Imaging; 2016 Feb 04; 43(2):259-269. PubMed ID: 26359191
    [Abstract] [Full Text] [Related]

  • 17. Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.
    Manabe O, Ohira H, Yoshinaga K, Sato T, Klaipetch A, Oyama-Manabe N, Ito YM, Tsujino I, Nishimura M, Tamaki N.
    Eur J Nucl Med Mol Imaging; 2013 Oct 04; 40(10):1558-66. PubMed ID: 23715906
    [Abstract] [Full Text] [Related]

  • 18. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB, Aurangabadkar HU, Bradfield JS, Ali Z, Kumar KS, Narasimhan C.
    Int J Cardiol; 2017 Feb 01; 228():717-722. PubMed ID: 27886616
    [Abstract] [Full Text] [Related]

  • 19. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
    Peretto G, Busnardo E, Ferro P, Palmisano A, Vignale D, Esposito A, De Luca G, Campochiaro C, Sartorelli S, De Gaspari M, Rizzo S, Dagna L, Basso C, Gianolli L, Della Bella P, Sala S.
    JACC Cardiovasc Imaging; 2022 Oct 01; 15(10):1771-1780. PubMed ID: 36202457
    [Abstract] [Full Text] [Related]

  • 20. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M, Hirata K, Tanimoto T, Ota S, Shiono Y, Yamano T, Matsuo Y, Ino Y, Yamaguchi T, Kubo T, Tanaka A, Akasaka T.
    Heart Rhythm; 2015 Dec 01; 12(12):2477-85. PubMed ID: 26111805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.